| (210) | Number of the EPO application | 18715441 |
| (220) | Filing date of the EPO application | 2018.03.16 |
| (80) | EPO patent specification publication (B) | EPB nr. 18/2023, 2023.05.03 |
| (110) | EPO patent number | 3595725 |
| (21) | Number of the application | e 2020 0091 |
| (71) | Name(s) of applicant(s), code of the country | Eisai R&D Management Co., Ltd., JP; |
| (72) | Name(s) of inventor(s), code of the country | KARR Craig D., US;
KORPAL Manav, US;
RIOUX Nathalie, US;
SMITH Peter Gerard, US; |
| (73) | Name(s) of owner(s), code of the country | EISAI R&D Management Co. Ltd., JP; |
| (54) | Title of the invention | COMBINATION THERAPIES FOR THE TREATMENT OF BREAST CANCER |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 45/06 (2006.01.01); A61K 31/445 (2006.01.01); A61K 31/519 (2006.01.01); A61P 35/00 (2006.01.01) |
| (19) | Country | JP |
| (41) | Date of publication of the application | 2020.02.29 |
| (30) | Priority | 201762472345 P, 2017.03.16, US |
| (86) | International application | PCT/US2018/022961, 2018.03.16 |
| (87) | International publication | WO 2018/170447, 2018.09.20 |